Study on Allicin-induced Necroptosis and Related Molecular Mechanism in Human Leukemia HL-60 Cells

Chun-lei XIONG,Qing-lin YAO,Pin FENG,Xiao-guang WANG,Jing-yi ZHANG
DOI: https://doi.org/10.13241/j.cnki.pmb.2017.35.008
2017-01-01
Abstract:Objective:The aim of this study was to investigate the anti-cancer effect of allicin in human leukemia HL-60 cells.We assayed necroptosis to determine the cell death type induced by allicin in HL-60 cells,and investigated the underlying molecular mechanisms with focus on JNK,RIP1 and RIP3 proteins.Methods:After treatment with allicin at different concentrations,the cell viability in HL-60 cells was measured by MTT method at different time points.The pan caspase inhibitor z-vad-fmk was used to investigate the involvement of anti-apoptotic mechanism.After treatment with 50 μM allicin,the LDH release and PI-positive cells was measured to detect necroptosis in HL-60 cells,and western blot was performed to detect the expression of RIP1 and RIP3,and the phosphorylation of JNK.HL-60 cells were treated with the selective JNK inhibitor SP600125,and co-immunoprecipitation (Co-IP) was performed to detect the interaction of RIP1 with RIP3.The cell viability,LDH release and PI-positive cells was measured after allicin and SP600125 treatment to investigate the involvement of JNK in allicin-induced anti-cancer effects in HL-60 cells.Results:Allicin exerted anti-cancer effects in human leukemia HL-60 cells,and some apoptosis-independent mechanisms were also involved in.Allicin at 50 μM induced necroptosis in HL-60 cells,which could be reversed by the necroptosis inhibitor necrostatin-1.Allicin at 50 μM significantly increased the expression of RIP1 and the phosphorylation of JNK,but had no effect on RIP3 expression.Allicin at 50 μM significantly enhanced the interaction of RIP1 with RIP3,and the selective JNK inhibitor SP600125 could reverse the anti-cancer effects of allicin in HL-60 cells.Conclusions:Allicin induced necroptosis through JNK-dependent enhancement of RIP 1-RIP3 interaction,which contributed to the anti-cancer effects of allicin in human leukemia HL-60 cells.
What problem does this paper attempt to address?